Stempoint Capital’s Praxis Precision Medicines PRAX Stock Holding History

Stempoint Capital’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.1M	Buy	56,267 +35,200	+167%	+$10.9M	3.48%	6
2025 Q4	$6.21M	Buy	+21,067	New	+$3.92M	1.07%	32
2025 Q3	–	Sell	-32,255	Closed	-$1.36M	–	99
2025 Q2	$1.36M	Buy	+32,255	New	+$1.23M	0.44%	42
2025 Q1	–	Sell	-134,178	Closed	-$10.3M	–	79
2024 Q4	$10.3M	Sell	134,178 -39,856	-23%	-$2.88M	2.59%	13
2024 Q3	$10M	Buy	174,034 +144,775	+495%	+$7.82M	3%	11
2024 Q2	$1.21M	Buy	29,259 +2,366	+9%	+$112K	0.36%	42
2024 Q1	$1.64M	Buy	+26,893	New	+$1.21M	0.44%	41

Other funds holding PRAX

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return